X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (80) 80
Patent (29) 29
Publication (15) 15
Newspaper Article (4) 4
Book Chapter (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
immunology (38) 38
animals (30) 30
index medicus (30) 30
humans (29) 29
chemistry (26) 26
metallurgy (26) 26
immunotherapy (25) 25
mice (22) 22
biochemistry (19) 19
human necessities (19) 19
hygiene (19) 19
medical or veterinary science (19) 19
preparations for medical, dental, or toilet purposes (19) 19
microbiology (18) 18
beer (17) 17
dendritic cells (17) 17
enzymology (17) 17
female (17) 17
mutation or genetic engineering (17) 17
spirits (17) 17
vinegar (17) 17
wine (17) 17
allergens (16) 16
allergy (15) 15
peptides (15) 15
sublingual immunotherapy (15) 15
allergens - immunology (14) 14
allergies (14) 14
compositions or test papers therefor (14) 14
condition-responsive control in microbiological orenzymological processes (14) 14
measuring or testing processes involving enzymes, nucleicacids or microorganisms (14) 14
processes of preparing such compositions (14) 14
asthma (13) 13
life sciences (13) 13
mice, inbred balb c (13) 13
organic chemistry (13) 13
administration, sublingual (12) 12
allergy and immunology (11) 11
dendritic cells - immunology (11) 11
regulatory t-cells (11) 11
investigating or analysing materials by determining theirchemical or physical properties (10) 10
measuring (10) 10
physics (10) 10
testing (10) 10
abridged index medicus (8) 8
allergic reaction (8) 8
hypersensitivity - therapy (8) 8
lymphocytes (8) 8
pollen (8) 8
[ sdv.imm ] life sciences [q-bio]/immunology (7) 7
cyclosporine - pharmacology (7) 7
desensitization, immunologic - methods (7) 7
hypersensitivity - immunology (7) 7
lymphocyte activation (7) 7
mesh : animals (7) 7
mice, inbred c57bl (7) 7
proteins (7) 7
specific therapeutic activity of chemical compounds ormedicinal preparations (7) 7
t cells (7) 7
cells, cultured (6) 6
efficacy (6) 6
expression (6) 6
gene expression (6) 6
grass-pollen immunotherapy (6) 6
hypersensitivity (6) 6
immune tolerance (6) 6
mass spectrometry (6) 6
mesh : mice (6) 6
pollen - immunology (6) 6
rhinitis (6) 6
rhinitis, allergic, seasonal - immunology (6) 6
rodents (6) 6
t-lymphocytes - immunology (6) 6
t-lymphocytes, regulatory - immunology (6) 6
th1 cells - immunology (6) 6
tolerance (6) 6
vaccines (6) 6
activation (5) 5
analysis (5) 5
antigen-specific tolerance (5) 5
antigens, plant - immunology (5) 5
asthma - immunology (5) 5
calcineurin (5) 5
cd4-positive t-lymphocytes - immunology (5) 5
cell differentiation (5) 5
cyclosporine (5) 5
cytokines (5) 5
flow cytometry (5) 5
house-dust mites (5) 5
immune system (5) 5
immunosuppressive agents (5) 5
inflammation (5) 5
male (5) 5
mechanisms (5) 5
mesh : cyclosporine (5) 5
mesh : lymphocyte activation (5) 5
ovalbumin - immunology (5) 5
proteomics (5) 5
t-cells (5) 5
t-lymphocytes - drug effects (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 2008, Volume 122, Issue 3, pp. 603 - 609.e5
A detailed characterization of oral antigen-presenting cells is critical to improve second-generation sublingual allergy vaccines. To characterize oral... 
sublingual immunotherapy | dendritic cell | mucosal immunity
Journal Article
Molecular Immunology, ISSN 0161-5890, 2006, Volume 43, Issue 11, pp. 1846 - 1854
Cyclosporin-A and FK506 block the calcineurin activity preventing the transcription of genes sharing NFAT-like binding sequences in their promoter region. We... 
Messengers RNA | RNA Splicing | T-Lymphocytes | Immunosuppressive agents | Gene transcription | gene transcription | COMPLEX | messengers RNA | MECHANISM | PHOSPHATASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSCRIPTION | IMMUNOLOGY | IDENTIFICATION | immunosuppressive agents | T-lymphocytes | GROWTH | CALCINEURIN | PROTEINS | EXPRESSION | CELL-ACTIVATION | RNA splicing | Cyclosporine - pharmacology | Genome - genetics | Molecular Sequence Data | RNA, Messenger - metabolism | Sequence Homology | Calcineurin Inhibitors | Protein Isoforms - metabolism | T-Lymphocytes - metabolism | Protein Isoforms - chemistry | T-Lymphocytes - drug effects | Base Sequence | Tacrolimus - pharmacology | Membrane Proteins - metabolism | Amino Acid Sequence | Introns - genetics | RNA Splice Sites - genetics | Membrane Proteins - genetics | Alternative Splicing - genetics | RNA, Messenger - genetics | Cells, Cultured | Gene Expression Regulation | Exons - genetics | Open Reading Frames - genetics | Alternative Splicing - drug effects | Animals | Membrane Proteins - chemistry | Lymphocyte Activation - drug effects | Mice | Protein Isoforms - genetics | Genetic engineering | Messenger RNA | Cyclosporine | T cells | Alternative Splicing | Introns | Lymphocyte Activation | Exons | Calcineurin | Membrane Proteins | Life Sciences | Immunology | Genome | Open Reading Fram
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 03/2004, Volume 279, Issue 11, pp. 10556 - 10563
Cyclosporin A (CSA) is an immunosuppressor used in organ transplantation. A recent proteomic analysis has revealed that activation of T cells in the presence... 
PERMEABILITY TRANSITION PORE | APOPTOSIS | IMPORT | TRANSLOCATION | MEMBRANE | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSCRIPTION | CALCINEURIN | ANTIGEN RECEPTOR | BINDING | CYCLOPHILIN | Green Fluorescent Proteins | Up-Regulation | Alternative Splicing | Cyclosporine - pharmacology | Humans | Molecular Sequence Data | Mitochondrial Proteins - genetics | RNA, Messenger - metabolism | Necrosis | Tissue Distribution | Flow Cytometry | Transfection | T-Lymphocytes - metabolism | Time Factors | Base Sequence | Cell Membrane - metabolism | Immunosuppressive Agents - pharmacology | Endopeptidase K - pharmacology | Amino Acid Sequence | Cell Line | Peptides - chemistry | Lymphocyte Activation | Membrane Proteins - genetics | Cytochromes c - metabolism | Mice, Inbred C57BL | Mitochondria - metabolism | Mitochondrial Proteins - biosynthesis | Reverse Transcriptase Polymerase Chain Reaction | Plasmids - metabolism | Blotting, Western | Membrane Proteins - biosynthesis | Animals | Protein Isoforms | Mice | Genome | In Vitro Techniques | Subcellular Fractions | DNA, Complementary - metabolism | Calcineurin - metabolism | Intracellular Membranes - metabolism | Microscopy, Fluorescence | Apoptosis | Luminescent Proteins - metabolism | cyclosporin A | CSTAD gene | FK506 protein | rapamycin | Cell Membrane | Immunosuppressive Agents | Peptides | Calcineurin | Cytochromes c | Intracellular Membranes | Cyclosporine | Mitochondrial Proteins | Life Sciences | Mitochondria | Immunology | Luminescent Proteins | T-Lymphocytes | Membrane Proteins | Endopeptidase K | Plasmids | RNA, Messenger | DNA, Complementary
Journal Article
Immunology Letters, ISSN 0165-2478, 2002, Volume 84, Issue 2, pp. 137 - 143
We have studied the effect of cyclosporin A (CSA) on the expression of genes involved in the immune response in mice bearing a transgenic T cell receptor... 
Cell surface molecule | Activation | T lymphocyte | Immunomodulators | cell surface molecule | HOMING RECEPTORS | BINDING-PROTEIN | INDUCTION | IMMUNOLOGY | PROTEIN KINASE-C | CIS-TRANS ISOMERASE | CALCINEURIN | SURFACE | immunomodulators | T-CELL ACTIVATION | activation | LYMPHOCYTES-T | CYCLOPHILIN | Transcription, Genetic - drug effects | Gene Expression - drug effects | Antigens, CD - biosynthesis | Cyclosporine - pharmacology | Cytochrome c Group - immunology | Lymphocyte Activation - genetics | Lymphocyte Activation - immunology | Flow Cytometry | T-Lymphocytes - drug effects | Female | Receptors, Antigen, T-Cell - immunology | Receptors, Chemokine - genetics | Cytokines - genetics | Immunosuppressive Agents - pharmacology | Receptors, Chemokine - drug effects | Cytochrome c Group - genetics | Cytokines - immunology | Cytochrome c Group - pharmacology | Immunization | Receptors, Chemokine - metabolism | Cells, Cultured | Mice, Transgenic | Antigens, CD - drug effects | Receptors, Chemokine - immunology | Reverse Transcriptase Polymerase Chain Reaction | Animals | Cytokines - drug effects | T-Lymphocytes - immunology | Mice | Receptors, Antigen, T-Cell - genetics | Gene Expression | Immunosuppressive Agents | Cytokines | T-Lymphocytes | Lymphocyte Activation | Cytochrome c Group | Cyclosporine | Receptors, Antigen, T-Cell | Life Sciences | Immunology | Transcription, Genetic | Receptors, Chemokine | Antigens, CD
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2008, Volume 122, Issue 3, pp. 603 - 609.e5
Background A detailed characterization of oral antigen-presenting cells is critical to improve second-generation sublingual allergy vaccines. Objective To... 
Allergy and Immunology
Journal Article
by Mendes-Ferreira, P and Maia-Rocha, C and Adao, R and Lourenco, A. P and Moura, C and Pinho, S and Areias, J. C and De Keulenaer, G. W and Leite-Moreira, A. F and Bras-Silva, C and Holzhauser, L and Lindner, D and Jenke, A and Schultheiss, H.- P and Westermann, D and Skurk, C and Misaka, T and Suzuki, S and Miyata, M and Kobayashi, A and Saitoh, S and Takeishi, Y and Czolbe, M and Pekarek, V and Williams, T and Panther, F and Strassen, J and Ritter, O and Voss, S and Nef, H. M and Szardien, S and Troidl, C and Kojonazarov, B and Visser, D and Hoffmann, J and Willmer, M and Hamm, C. W and Moellmann, H and Ljubojevic, S and Sedej, S and Sacherer, M and Leitinger, G and Kockskaemper, J and Pieske, B and Vorobyeva, N. M and Dobrovolsky, A. B and Titaeva, E. V and Kirienko, A. I and Panchenko, E. P and Nakamura, R and Matsue, Y and Mizukami, A and Ohno, M and Suzuki, M and Matsumura, A and Hashimoto, Y and Rosiak, M and Postula, M and Kaplon-Cieslicka, A and Trzepla, E and Czlonkowski, A and Filipiak, K. J and Opolski, G and Kosior, D. A and Andersson, T and Nagy, P and Niazi, M and Nylander, S and Wallentin, L and Mendell, J and Johnson, L and Ridout, G and He, L and Chen, S and Petrkova, M and Schneiderova, P and Kriegova, E and Kolar, Z and Taborsky, M and Petrek, M and Khuseyinova, N and Schnabel, R and Zeller, T and Gori, T and Schulz, A and Espinola-Klein, C and Lackner, K. J and Blankenberg, S and Muenzel, T. F and Wild, P. S and Amabile, N and Cheng, S and Larson, M. G and Ghorbani, A and Mc Cabe, E and Griffin, G and Cohen, K. S and Tedgui, A and Boulanger, C. M and Wang, T. J and ... and on behalf of BBC ONE investigators and on behalf of WHICH? Trial Investigators and on behalf of EPES Acute Cardiac Care group and on behalf of Interventional Genetic Study Group in Cardiovascular Disease's and on behalf of HPS2-THRIVE Collaborative Group and on behalf of Advantageous Predictors of Acute Coronary Syndrome Evaluation (APACE) and on behalf of The Milan and New-Tokyo Registry and on behalf of SAFETY Investigators and on behalf of Advance CRT Investigators and on behalf of the ARVA Investigators and on behalf of TIMI Study Group and on behalf of REFINE ICD Investigators and on behalf of RO-AHFS Study Investigators and on behalf of The PASCAL Investigators and on behalf of the KorHF investigators and on behalf of TECAM and on behalf of The INSIGHT (R)XT investigators and on behalf of ATA-AF investigators and on behalf of The ODIN Participants and on behalf of CREDO-Kyoto Registry Cohort-2 Investigators and on behalf of AHEAD investigators and on behalf of the RESET investigators and on behalf of ABSORB Cohort B and on behalf of RE-LY Trial Investigators and on behalf of the CORONA Study Group and on behalf of PROTECTOME and on behalf of CoLaus Study and on behalf of OFRECE Study and on behalf of BBK Registry and on behalf of FAST-MI 2010 and on behalf of ATOLL investigators and on behalf of HARVEST study group and on behalf of Royal Brompton Hospital NIHR Cardiovascular Biomedical Research Unit and on behalf of the PROSPER study group and on behalf of MAGGIC study group and on behalf of the DANPACE Investigators and on behalf of German Conn's Registry and on behalf of NANOPLASTY group and on behalf of j-Cypher Registry and on behalf of NIL-CHF Study Investigators and on behalf of the FAST-MI 2010 investigators and on behalf of Competence Network Heart Failure and on behalf of Gothia Cardiovascular and on behalf of OPTIMISE CRT Investigators and on behalf of EVEREST trial investigators and on behalf of The Tohoku Acute Heart Failure Registry and on behalf of investigators of the national registry of ACS, Portuguese Society of Cardiology and on behalf of BIOSOLVE-I Investigators and on behalf of Department of Cardiology, Second Hospital of Tianjin Medical University and on behalf of THALES Registry Investigators and on behalf of STICH Investigators and on behalf of Young @ Heart Investigators and on behalf of PROCARDIS Consortium and on behalf of PEGASO and on behalf of The SWEDEHEART group and on behalf of BWGIC (Belgian Working Group of Invasive Cardiology and on behalf of Med in NRW and For The Topp Registry Investigators and on behalf of PRISON and on behalf of ARISTOTLE investigators and on behalf of the RACE II investigators and on behalf of Euro Heart Survey PCI registry investigators and on behalf of the SPICE investigators and on behalf of The ISAR REACT 4 Investigators and on behalf of Yokohama Medical Center Clinical Research group and on behalf of DiaRegis-Study-Group and on behalf of The RHYTHM-AF Study Scientific Committee and on behalf of the Korea Acute Myocardial Infarction Registry and on behalf of AMIS Plus Investigators and on behalf of SYNTAX Investigators and on behalf of Advantage Predictors of Acute Coronary Syndrome Evaluation and on behalf of CREATE investigator group and on behalf of Follow Your Heart Project and on behalf of SYNTAX Trial Investigators and on behalf of WELCOME Study Investigators and on behalf of Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK) investigators and on behalf of investigators of the national registry of ACS, Portugese Society of Cardiology and on behalf of EVITA-HF (Evidence Based Treatment - Heart Failure) and on behalf of ESTROFA and on behalf of Second Department of Internal Medicine and on behalf of Korea Acute Myocardial Infarction Registry and on behalf of PRAGUE-2 and on behalf of German Diabetes and Dialysis Study Investigators and on behalf of Hull LifeLab and on behalf of on behalf of the DYDA Investigators and on behalf of OFICA study group and on behalf of BASKET-PROVE and on behalf of the Triple-Site versus Standard Resynchronization Therapy Study (TRUST CRT) Investigators and on behalf of Scripps Translational Science Institute and on behalf of OMEGA study group and on behalf of PL-ACS Invastigators and on behalf of German Aortic Valve Therapy Registry and on behalf of TO BELIEVERS and on behalf of PREDICTION Study Group and on behalf of The REACH registry investigators and on behalf of PL-ACS Investigators and on behalf of KNHI and on behalf of Emerging Concepts in Cardiovascular Medicine and on behalf of CHART-2 Investigators and on behalf of the Fushimi AF Registry investigators and on behalf of Brasilian Heart Study Group and on behalf of Taiwan acute coronary syndrome full spetrum registry study group
European Heart Journal, ISSN 0195-668X, 08/2012, Volume 33, Issue suppl 1, pp. 339 - 653
Journal Article
Journal of Immunology, ISSN 0022-1767, 03/2005, Volume 174, Issue 5, pp. 2730 - 2737
The role of Notch signaling in T cell commitment during lymphoid development is well established. However, the identity of the ligand that triggers this... 
Journal Article
European Journal of Immunology, ISSN 0014-2980, 01/2002, Volume 32, Issue 1, p. 77
Journal Article
European Journal of Immunology, ISSN 0014-2980, 01/2002, Volume 32, Issue 1, pp. 77 - 86
Embryonic thymic lobes cultured in vitro in the presence of deoxyguanosine (dGuo) are accepted in fully mismatched recipients. The proposed explanation for... 
Tolerance | Transplantation | T lymphocyte | Cytokine | Thymus | deoxyguanosine
Journal Article
Transplantation, ISSN 0041-1337, 07/2000, Volume 70, Issue 2, pp. 340 - 348
Journal Article
11/2017
The present invention concerns the use of immunoglobulins of IgG1 type, and more generally of ligands of the CD32 receptor, for the treatment of inflammatory... 
METALLURGY | PEPTIDES | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.